Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Debt Repaid

Amneal Pharmaceuticals Inc Debt Repaid Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Debt Repaid from 2016 to 2018.
  • Amneal Pharmaceuticals Inc Debt Repaid for the quarter ending December 12, 2018 was $-159m a 97.73% decrease of -155m year over year
  • Amneal Pharmaceuticals Inc Debt Repaid for the last 12 months ending December 12, 2018 was $-784m a 101.34% decrease of -795m year over year
  • Amneal Pharmaceuticals Inc Annual Debt Repaid for 2018 was $-784m a 98.23% decrease of -770m from 2017
  • Amneal Pharmaceuticals Inc Annual Debt Repaid for 2017 was $-14m a -161.86% increase of 22m from 2016
  • Amneal Pharmaceuticals Inc Annual Debt Repaid for 2016 was $-36m a 64.25% decrease of -23m from 2015
Other Cash Flow Metrics:
  • Amneal Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $260m a 89.59% increase of 233m year over year
  • Amneal Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $215m a 94.17% increase of 202m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin

Quarterly AMRX Debt Repaid Data

12/2018$-159m
09/2018$68m
06/2018$-690m
03/2018$-4m
12/2017$-4m
09/2017$-4m
06/2017$21m
03/2017$-28m
12/2016$22m

Annual AMRX Debt Repaid Data

2018$-784m
2017$-14m
2016$-36m
2015$-13m
2014$-40m